144 related articles for article (PubMed ID: 12056530)
1. Fast- and slow-release tablets for oral administration of flavonoids: rutin and quercetin.
Lauro MR; Torre ML; Maggi L; De Simone F; Conte U; Aquino RP
Drug Dev Ind Pharm; 2002 Apr; 28(4):371-9. PubMed ID: 12056530
[TBL] [Abstract][Full Text] [Related]
2. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
3. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
4. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of colon targeted drug delivery systems for albendazole using kneading, extrusion and compaction technology.
Emeje M; Nwabunike P; Isimi Y; Kunle O; Ofoefule S
Yao Xue Xue Bao; 2009 Oct; 44(10):1152-8. PubMed ID: 20055141
[TBL] [Abstract][Full Text] [Related]
6. Thermogravimetric investigation of the hydration behaviour of hydrophilic matrices.
Segale L; Giovannelli L; Pattarino F; Conti S; Maggi L; Grenier P; Vergnault G
J Pharm Sci; 2010 Apr; 99(4):2070-9. PubMed ID: 19780132
[TBL] [Abstract][Full Text] [Related]
7. II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: co-milling.
Maggi L; Bruni G; Maietta M; Canobbio A; Cardini A; Conte U
Int J Pharm; 2013 Sep; 454(1):568-72. PubMed ID: 23872227
[TBL] [Abstract][Full Text] [Related]
8. Formulation of biphasic release tablets containing slightly soluble drugs.
Maggi L; Machiste EO; Torre ML; Conte U
Eur J Pharm Biopharm; 1999 Jul; 48(1):37-42. PubMed ID: 10477326
[TBL] [Abstract][Full Text] [Related]
9. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
Emeje MO; Kunle OO; Ofoefule SI
Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets.
Varshosaz J; Tavakoli N; Roozbahani F
Drug Deliv; 2006; 13(4):277-85. PubMed ID: 16766469
[TBL] [Abstract][Full Text] [Related]
11. Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Int J Pharm; 2020 Mar; 577():119080. PubMed ID: 31988030
[TBL] [Abstract][Full Text] [Related]
12. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
13. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of modified release tablets containing isoniazid using swellable polymers.
Akhtar MF; Rabbani M; Sharif A; Akhtar B; Saleem A; Murtaza G
Afr J Tradit Complement Altern Med; 2011; 8(3):250-9. PubMed ID: 22468003
[TBL] [Abstract][Full Text] [Related]
15. Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites.
Azad M; Arteaga C; Abdelmalek B; Davé R; Bilgili E
Drug Dev Ind Pharm; 2015; 41(10):1617-31. PubMed ID: 25347144
[TBL] [Abstract][Full Text] [Related]
16. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
Ebube NK; Jones AB
Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
[TBL] [Abstract][Full Text] [Related]
17. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
18. Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets.
Varshosaz J; Tavakoli N; Eram SA
Drug Deliv; 2006; 13(2):113-9. PubMed ID: 16423799
[TBL] [Abstract][Full Text] [Related]
19. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies.
Pan J; Lu W; Li C; Wang S; He L
Arch Pharm Res; 2010 Aug; 33(8):1209-16. PubMed ID: 20803124
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
Gundogdu E; Koksal C; Karasulu E
Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
